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Abstract 
In this study, urine from a calcium oxalate kidney 
stone former was ultrafiltered (10 kD cut-off). Crystal-
lization was induced in the ultrafiltrate and retentate 
fractions as well as in a sample of the whole urine. The 
progress of crystallization was monitored by Coulter 
Counter and flow cytometry techniques. (The latter has 
not been used in studies of the role of urinary macro-
molecules in urolithiasis). Deposited crystals were 
examined by scanning electron microscopy. Results 
indicated that urinary macromolecules in this subject are 
inhibitors of nucleation and aggregation. These results 
agree with the findings of some workers but disagree 
with those of others. Indeed, studies on the role played 
by urinary macromolecules in promoting or inhibiting 
urolithiasis have failed to produce consistent findings. 
Examination of the literature reveals that a wide variety 
of experimental techniques and crystallization systems 
have been used in these studies and that this might be 
the cause of the inconsistencies. Based on reported 
experiences and those of the present study, a standard 
reference crystallization system is proposed. The key 
elements of this system involve the use of real urine, 
ultrafiltration, continuous crystalliz.er equipment, Coulter 
Counter procedures and scanning electron microscopy. 
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system, ultrafiltration, flow cytometry, calcium oxalate, 
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Introduction 
During the past several years many studies have 
addressed the question of the role played by urinary 
macromolecules (UMM) in urolithiasis. Particular inter-
est has been focused on their influence on calcium ox-
alate stone formation. Three general approaches have 
been adopted. First, workers have investigated the na-
ture and composition of UMM in actual stones and have 
examined the structure and ultrastructure of such concre-
tions [38, 44, 62]. Second, several studies have at-
tempted to identify differences in the composition and 
concentration of UMM in the urine of stone formers and 
normal controls [3 , 4, 15, 16, 17, 27 , 29, 31, 37, 57, 
61] . Finally, in vitro crystallization studies have been 
conducted in aqueous solutions [1 , 12, 20, 33 , 34, 36, 
39, 43, 56, 58], synthetic urines [9, 10, 18, 32, 40, 42, 
45, 63] and real urines [2, 5, 6, 11, 21, 24, 47, 48 , 50 , 
51, 55, 59 , 60] in the presence or absence of various 
UMM which have either been added to or removed from 
the test sample. 
Studies employing the first approach are in agree-
ment that hyaluronic acid and heparan sulphate are the 
main glycosaminoglycans in the matrix component of 
urinary calculi while chondroitin sulphate is absent [38, 
44]. This has been interpreted as indicating that the 
former are promoters [38] while the latter is an inhibitor 
of stone formation [38] . 
Results obtained in studies employing the second 
approach are inconsistent. Some studies have reported 
significant differences between stone formers and nor-
mals with respect to UMM excretions or concentrations 
or composition [15, 17, 31, 37, 61] while others have 
failed to find any such differences [4, 16, 27, 29, 57]. 
With regard to the third approach, the literature 
abounds with numerous examples of apparently conflict-
ing findings, and it is in this area of investigation that 
we wish to focus attention. Some studies have found 
that UMM are inhibitors of calcium oxalate "growth" [ 1, 
2, 5, 6, 12, 34, 36, 39, 56] - a term used synonymously 
with "formation" and "precipitation" - while others have 
found them to be promoters [24, 48, 50, 51]. On the 
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Figure l. Coulter Counter plots of particle number 
versus (vs) time for FILT, UF and RET fractions. 
other hand, several workers have conducted sophisticat-
ed experiments in which they have been able to be more 
specific about the aforementioned crystalliz.ation and pre-
cipitation processes. These studies have shown that 
UMM are inhibitors of calcium oxalate crystal growth 
[9, 20, 21, 42, 43, 45, 52, 59, 60, 63] and inhibitors of 
aggregation [10, 11, 19, 26, 33, 45, 52, 55 , 58] but are 
promoters of calcium oxalate nucleation [9, 21, 42, 45 , 
47, 59, 60, 63] . As might be expected, there is not 
much consensus in these findings either. For example, 
in contrast to some of the previously mentioned studies, 
Edyvane and co-workers showed that UMM (MW > 10 
kD) did not affect the calcium oxalate metastable limit 
and concluded that therefore they had no effect on nucle-
ation [11] while Gill and associates found that UMM 
(MW > 12 kD) inhibited nucleation [18]. Similarly, 
Gjaldbaek [19] failed to demonstrate any inhibition by 
chondroitin sulphate while Kohri et al. [32], in their 
studies of three UMM, found them to be inhibitors of 
nucleation and promoters of growth. In a more recent 
study, Kavanagh and co-workers found that heparin and 
hyaluronic acid significantly reduced nucleation rates but 
increased growth rates [30] . 
The complexity ofUMM inhibitor/promoter activity 
is highlighted by studies which have shown that different 
UMM fractions might have different functions [2, 51]. 
The concept of synergism too has been raised by some 
workers [2, 21, 52]. Alternatively, UMM are often 
considered as though they were a single substance with-
out reference to the fact that the term includes glycos-
aminoglycans, Tamm-Horsfall proteins and many other 
substances, each of which may have its own inhibitory 
or promotory effects upon crystal formation. Others 
have drawn attention to more fundamental issues con-
cerning, for example, the possible modification of UMM 
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Figure 2. Coulter Counter plots of particle volume vs 
time for FILT, UF and RET fractions. 
structure and hence activity as a result of the particular 
isolation or concentration procedure employed [2, 34]. 
Many aspects of the relationship between UMM and 
calcium oxalate stone formation remain ill-defined and 
unresolved. The present paper reviews methodologies 
and approaches that have been employed in studies of 
UMM and describes a new and powerful technique, flow 
cytometry, that might prove useful in elucidating the role 
of UMM in urolithiasis. In addition, an attempt is made 
in this paper to identify, on theoretical grounds, why 
conflicting results have been reported so frequently in 
the past and to propose a standardized system that 
investigators might consider implementing. 
Materials and Methods 
A single 24-hour urine (pH 5. 8) was collected from 
a male idiopathic kidney stone former of age 24 years. 
The specimen was stored in a glass bottle at 4 °C during 
the collection period. No preservative was present. 
Crystals, cellular debris and proteinaceous material were 
removed by sieving (74 µm) and filtration {Sartorius cel-
lulose acetate 0.45 µm filter (Sartorius AG , Goettingen, 
Germany)} , although it is recognized that material lost 
in this way may include substances on which macro-
molecules may be adsorbed. Henceforth, this urine 
fraction will be referred to as FILT. 
Aliquots of the FILT fraction were then ultrafiltered 
using an Amicon stirred ultrafiltration cell (Amicon 
Corp., Danvers, MA, USA) containing a Diaflo Type 
YM 10 membrane (Amicon) with a molecular weight cut-
off of 10 kD. A pressure of 3.7 atm (2812 torr) was 
maintained within the cell by nitrogen gas. Two further 
fractions, ultrafiltrate and retentate (henceforth, referred 
to as UF and RET), were obtained from this procedure. 
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Figure 3. Flow cytometer plots of particle number vs time for FILT, UF and RET fractions. 
Figures 4-6. Flow cytometer plots of particle number vs time in four relative size zones in: the FILT fraction (Fig. 
4); the UF fraction (Fig. 5); and the RET fraction (Fig. 6). 
--------------------------------------------------------------------------------------------------
The degree of ultrafiltration was 3-fold. After ultrafil-
tration was complete, the membrane was examined for 
solid deposits by optical microscopy. 
The calcium oxalate limit of metastability in the 
FILT fraction was determined by titration with aqueous 
sodium oxalate solution and was defined by the concen-
tration of sodium oxalate which caused a sudden in-
crease in particle number. A flow cytometer (described 
below) was used for this purpose. 
Calcium oxalate crystallization was then induced at 
37°C in the fractions FILT, UF and RET, by adminis-
tration of a dose of aqueous sodium oxalate equivalent 
to the previously determined metastable limit of the 
FILT fraction. This amounted to the addition of 1 cm3 
of 0.04 M sodium oxalate solution per 100 cm3 of test 
fraction. Since the dose given to each fraction was iden-
tical, their respective responses could be compared 
effectively. 
The progress of calcium oxalate crystallization in 
each fraction was followed by two independent tech-
niques: Coulter Counter and flow cytometry. A Coulter 
Multisizer (aperture size 140 µm) and an Epics Flow 
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Cytometer equipped with an argon laser were used for 
this purpose. Both instruments were obtained from 
Coulter Electronics Ltd., Luton, England. Alignment 
and focusing of the sample stream and laser beam (flow 
cytometer) were performed daily. While the Coulter 
Counter has been widely used for the measurement of 
particle size-distribution profiles in many studies involv-
ing urinary calcium oxalate crystallization processes, 
flow cytometry has only recently been used for the first 
time in this field [49) . Its application in the study of 
urinary macromolecules has not been previously re-
ported. Briefly, in a flow cytometer, particles in liquid 
suspension are passed through a laser beam. The scat-
tered light is detected and provides data concerning par-
ticle size, number and morphology. Crystallization was 
monitored for 90 minutes (as advocated by Ryall and co-
workers [53)) using both techniques. In addition to 
Coulter and flow cytometry techniques, scanning elec-
tron microscopy (SEM) was performed on the deposited 
crystals in each fraction. A Leica Cambridge S440 
(Leica, Rockleigh, NJ) sigma scanning electron micro-
scope was used for this purpose. 
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Figures 7-9. Flow cytometer plots of number vs time 
for different particle types (i.e., morphologies) in: the 
FILT fraction (Fig. 7); the UF fraction (Fig. 8); and the 
RET fraction (Fig. 9). 
Results 
Coulter Counter plots of particle number vs time 
and total particle volume vs time for the three fractions 
are given in Figures 1 and 2 respectively. Figure 3 
gives plots of total particle number vs time for each 
fraction as determined by flow cytometry. Each of the 
three plots shown in Figure 3 can be re-plotted individu-
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ally to show the distribution of particles in various arbi-
trarily defined size zones. In the present study, the dis-
tribution was divided into four such zones: small, medi-
um, large and very large; these are shown as a function 
of time in Figures 4, 5 and 6. (Definition of these size 
zones is based on relative size and not on absolute size 
[49] . However, zone sizes can be calibrated by using 
beads of appropriate cross section). As mentioned ear-
lier, flow cytometry can distinguish between different 
morphologies and can output data concerning the number 
of particles corresponding to different shapes. Figures 
7, 8 and 9 show that two different types of structure 
were identified in each fraction; the plots show how the 
number of particles of both types varied with time. 
No solid material was detected on the membrane af-
ter ultrafiltration. However, SEM of the FILT specimen 
revealed the presence of only a few calcium oxalate 
dihydrate (COD) crystals. These were small ( < 5 µm 
cross section) and mainly single, but small aggregates 
were occasionally observed (Fig. 10). The UF fraction 
had more crystals than in the FILT sample; these ap-
peared to be slightly larger (Fig. 11). In addition, ag-
gregates were observed more frequently (but not in great 
numbers), and these were large (Fig. 12). Apatite de-
posits (Figs. 13 and 14) confirmed by energy dispersive 
X-ray analysis were also detected. In some cases, 
embedded COD crystals were observed (Fig. 13). RET 
fractions did not show any COD crystals. 
Discussion 
It must surely be a cause of concern and a source of 
frustration to investigators that studies on the role of 
UMM in calcium oxalate crystal (and stone) formation 
have continuously failed to produce consistent results. 
There are several possible explanations for this lack of 
reproducibility and agreement. 
Macromolecular separation 
Isolation and separation procedures can induce con-
formational changes in UMM which will modify their 
adsorption onto mineral surfaces as well as their binding 
properties [2, 34] . Among the procedures that have 
been used frequently are dialysis [l, 6, 18, 20, 36, 56, 
58] and ultrafiltration [2, 5, 11 , 12, 21, 24, 31, 33 , 42, 
47, 48, 50, 51 , 55 , 60, 63]. Bio-Gel filtration, ion 
exchange chromatography and protein precipitation have 
also been used [34]. Thus, the role of UMM, as de-
duced in in vitro experiments, may be influenced by the 
technique used for their original isolation. 
Nature of the crystallization system 
It has been pointed out by other workers that most 
of the discrepancies concerning the role of UMM are 
due to the wide variety of crystallization systems that 
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have been employed [14, 32). These include batch [6, 
10, 19, 20, 58), seed [3, 12, 19, 33, 36, 43, 52, 63], 
continuous [9, 32, 42, 45), constant composition [34], 
rotary evaporation [21, 24, 50, 51, 60), oxalate loading 
[2, 5, 11, 18, 39, 55, 63], freezing [21, 60], paperwick 
[56] and vapour diffusion [7] models. Hesse and co-
workers [28] have correctly stated that crystallii.ation 
systems are not identical, and that therefore different re-
sults are attributed to the specific characteristics of the 
experiment. We wish to endorse this view and to elab-
orate upon it by suggesting that the activity of UMM is 
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Figures 10-14. Scanning electron micrographs of: 
small, single and aggregated calcium oxalate dihydrate 
crystals occasionally observed in the FILT fraction (Fig. 
10); calcium oxalate dihydrate crystals (Fig. 11) and 
aggregate (Fig. 12) observed in the UF fraction; and 
apatite deposits with embedded calcium oxalate dihydrate 
crystals (arrows; Fig. 13) and apatite deposits (Fig. 14) 
observed in the UF fraction. 
----------------------------
highly sensitive to and dependent upon the crystalliz.ation 
milieu in which they are present. This milieu encom-
passes not only the nature of the crystalliz.ation system 
but also possible additive, competitive or synergistic 
influences of all UMM components, some of which may 
be inhibitors and some of which may be promoters. 
Others may even have a dual inhibitor-promoter capacity 
depending on experimental conditions [23, 25). Indeed, 
the performance of UMM may also be dependent on the 
presence of other urinary components which themselves 
may influence the capacity (of UMM) to promote or 
inhibit the different crystallization processes. Prominent 
amongst these is monosodium urate which has been 
shown to reduce the inhibitory potency of certain UMM 
in inorganic solutions [12, 39, 54). Thus, conditions 
operating in a batch crystalliz.er, for example, will pro-
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duce a totally different milieu to that existing in a con-
tinuous crystallizer or rotary evaporator. We suggest 
that the different conditions existing in the different crys-
tallization systems induce a "ripple effect" in which nu-
merous inter-related processes involving inhibition and 
promotion of nucleation, growth and aggregation interact 
with each other to finally produce a nett, system-depend-
ent mechanism. 
Detection and monitoring procedures 
We believe that interpretation of the role played by 
UMM in calcium oxalate crystallization depends upon 
the very method used for the detection and monitoring 
of the crystallization processes which are actually occur-
ring in the samples under investigation. Detection pro-
cedures which have been employed are Coulter Counter 
techniques [5, 11, 32, 45, 52, 55, 58], radioactive assay 
[6, 12, 18, 19, 33, 36, 39, 43, 50, 51, 63], optical 
methods [21, 24, 60], electron microscopy [11, 32, 55], 
specific ion electrode [2, 34], particle analyzer (elec-
trorone/celloscope counter type) [9, 42], nephelometry 
[10, 22, 47, 48], colorimetry [20] and fluorimetry [56]. 
Because these techniques have different sensitivities and 
detection limits, it is likely that they monitor different 
stages and aspects of the crystallization processes which 
are taking place. Therefore, interpretations based on 
Coulter Counter measurements, for example, may differ 
substantially from those based on turbidity determina-
tions, even though the same urine specimen and the 
same method of inducing crystallization are used. Dis-
crepancies in interpretation are further compounded by 
confusion with respect to the crystallization mecha-
nism(s) (nucleation, growth or aggregation) that is (are) 
actually being measured by the particular detection 
process being used. 
In the present study, calcium oxalate crystallization 
was induced in different macromolecular fractions of the 
same urine and was monitored by two independent tech-
niques: Coulter Counter and flow cytometry. While the 
former has been widely used for such studies, the latter 
has only recently been implemented in the investigation 
of urinary calcium oxalate crystallization [ 49]. Its appli-
cation in the study of UMM has not been reported previ-
ously. 
Figure 1 shows that after 90 minutes, the number of 
particles formed in the different fractions are in the 
sequence UF > FILT > RET. This demonstrates that 
nucleation occurs to a lesser extent in the presence of 
UMM than in its absence. A possible inference is that 
UMM are inhibitors of calcium oxalate nucleation. This 
contradicts findings of an earlier study of ours which 
was conducted under similar conditions except that tur-
bidimetry and Malvern particle size techniques were em-
ployed [47]. In that study, UMM were found to be pro-
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moters of calcium oxalate nucleation. The different con-
clusions drawn in the two studies are due to different 
techniques used to monitor the crystallization processes. 
These techniques are based on different sensing princi-
ples, and thus, data acquired by each will have different 
significance and may elicit different interpretations. 
Figure 2 shows that the final crystal volumes are in 
the same sequence as crystal numbers. Thus, the vol-
ume of crystals formed in UF is greater than that formed 
in other fractions. There are three mechanisms by 
which this could occur. First, it could arise simply from 
the presence of the largest number of particles in this 
fraction (as shown in Fig. 1). This is consistent with 
our suggestion that UMM are nucleation inhibitors. 
Second, larger crystal volumes could occur in UF if big-
ger particles were present in this fraction. This implies 
that UMM could be inhibitors of growth. 
Third, when crystal aggregation occurs with accom-
panying entrapment of solution, "particle" volume will 
increase. In such an event, the smaller particle volumes 
observed in the presence of UMM (FILT and RET) sug-
gest that UMM may be inhibitors of crystal aggregation. 
Thus, Coulter Counter data, for this particular 
specimen, yield several possibilities for the role of 
UMM. The data suggest that UMM are probably nucle-
ation inhibitors, but that they may also be growth and/or 
aggregation inhibitors. 
Flow cytometry data for total particle numbers in 
the three fractions (Fig. 3) show the sequence FILT > 
UF > RET. It is apparent that FILT and UF occupy 
different positions in this sequence compared to that 
observed by Coulter techniques. Nevertheless, in both 
sequences FILT > RET and UF > RET, indicating that 
particle numbers are lower in the fraction containing 
concentrated levels ofUMM. We interpret these results 
as suggesting that UMM in this sample are nucleation 
inhibitors if they are present in high concentrations. 
This supports our Coulter data but qualifies concentra-
tion as an important factor. The observation, by flow 
cytometry, that FILT > UF indicates that, in this sub-
ject, UMM may be nucleation promoters when present 
in normal concentrations. As has been mentioned earli-
er, the role played by UMM as promoters or inhibitors 
is dependent on concentration. In a previous study in-
volving urine from non-stone formers, we reported that 
UMM are promoters of nucleation [47]. The present 
study, involving stone forming urine has confirmed this 
and shown that, at higher concentrations, inhibition 
might occur. 
Comparison of Figures 4, 5 and 6 shows that the 
number of "very large" particles in all fractions is negli-
gible. However, "large" particles are deficient in the 
RET fractions, suggesting that UMM may be inhibitors 
of growth and/or aggregation. "Small" and "medium" 
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particles follow a similar sequence which confirms this 
effect. However, the inhibitory effect might only occur 
in the concentrated RET fractions while an entirely dif-
ferent effect might occur when lower concentration lev-
els of UMM are present. 
The flow cytometer graphs for particle morphology 
(Figs. 7, 8 and 9) show that there are significant num-
bers of two "types" present in all fractions. The exis-
tence of a second shape (whatever it might be) is inter-
preted as being indicative of aggregation. Numbers of 
the predominant shape (type 1) follow the sequence RET 
< UF < FILT while numbers of the aggregated shape 
(type 2) follow the sequence RET < UF = FILT. 
Thus, aggregation occurs to a lesser extent in RET frac-
tions which have concentrated levels of UMM suggest-
ing that the latter are inhibitors of aggregation. This 
supports our interpretation of the size distribution data. 
It may be further argued that since aggregation does not 
occur to a great extent in RET, higher particle numbers 
would be expected in this fraction . However, to the 
contrary, lower numbers are recorded. This observation 
provides further evidence in support of UMM being 
inhibitors of nucleation. 
Our SEM observations are unable to conclusively 
demonstrate the role of UMM with respect to nucleation 
and growth. However, the presence of aggregates in UF 
samples and their absence in FIL T and RET fractions 
support our Coulter and cytometer data which suggest 
that UMM are inhibitors of calcium oxalate aggregation. 
We are unable to explain the presence of apatite in UF 
samples. 
It must be emphasized that it was not our intention 
in this paper, nor was it an objective of the present 
study, to make a definitive statement concerning the 
effect of UMM on different crystallization mechanisms. 
To do this , an in depth investigation involving many 
urines would be required. Rather, we simply wish toil-
lustrate that different techniques can lead to different, 
and sometimes incomplete, conclusions. Indeed, inspec-
tion of Figures 1 and 3 shows that interpretation of the 
kinetic plots at different stages of crystallization might 
yield different conclusions. We also wish to use the 
data, obtained from only one patient, to demonstrate that 
flow cytometry provides very useful information and that 
it might prove to be a valuable tool in this field, as has 
been the case with the Coulter Counter. 
Crystallization mediwn 
In the light of the above arguments, it should be ob-
vious that the crystallization medium will be of crucial 
importance in determining the nature of the crystalliza-
tion which occurs. Thus, experiments carried out in 
aqueous solutions or in synthetic urines cannot be com-
pared with each other (unless the chemical composition 
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is constant in all the test solutions) or with those per-
formed in whole urines. Although results obtained from 
such solutions, i.e., aqueous or synthetic, provide useful 
information about basic inhibition and promotion mecha-
nisms, they are of limited value since data cannot be 
extrapolated directly to real urine conditions. 
Hypothetical standard crystallization model 
Thus, the problem faced by investigators is that, in 
order to make a meaningful and valid assessment of 
their results, comparisons must be effected with other 
studies in which precisely the same procedures and con-
ditions were operative. Unfortunately, this is not easy 
to achieve because of the wide diversity of experimental 
systems that have been employed. 
It is clear that a standard reference crystallization 
model is required. Such a model should define: the 
method by which the UMM are isolated, concentrated or 
separated; the crystallization system itself, e .g . , continu-
ous crystallizer or rotary evaporator; and a monitoring 
procedure, e.g., Coulter or specific ion electrode, which 
allows a distinction to be made between the various 
crystallization mechanisms which might occur. It is also 
of fundamental importance to define terminology [41]. 
Having described the features required of a standard 
crystallization model, the challenge which must now be 
addressed concerns identification of the various elements 
of such a model which best satisfies or meets these re-
quirements. Ideally, individual laboratories should un-
dertake comparative studies in which different techniques 
for separating UMM, different crystallizers and different 
crystal monitoring procedures are investigated to estab-
lish which of these are most suitable and which combi-
nation of these best complement each other. Such an 
approach would, no doubt, enable an appropriate system 
to be defined. However, it is unlikely that any single 
laboratory would be able to undertake studies of this na-
ture because of obvious financial and logistical con-
straints. Therefore, any proposal for a standard refer-
ence model will have to be based on existing knowledge 
and the documented experience of the many investigators 
who have used a variety of crystallization systems in 
their studies of UMM. 
Consideration of the literature shows that the most 
widely used method for the separation of UMM is ultra-
filtration [2, 5, 11, 12, 21, 24, 31, 33 , 42, 47, 48, 50, 
51, 55 , 60, 63] . Reservations have been expressed by 
some authors that this procedure may modify the activity 
of UMM [2, 34], but this does not appear to have been 
demonstrated conclusively. Moreover, it has been 
shown that urinary concentrations of sodium potassium 
calcium, magnesium, phosphate, oxalate, ~rate, pyro~ 
phosphate and citrate are unaltered by this technique [ 11, 
50], and that it does not affect the metastable limit of the 
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urine [11, 55] . This technique has an advantage over di-
alysis since it yields two fractions for study, an ultrafil-
trate and a concentrated retentate fraction, whereas the 
latter yields only the retentate fraction . Therefore, we 
propose that the standard method for separating and con-
centrating UMM be ultrafiltration. 
Choice of the crystallizer itself, i.e., the method by 
which crystallization is induced, is of paramount impor-
tance in establishing a standard reference model. Sys-
tems which attempt to simulate in vivo conditions and 
crystallization processes must take precedence over those 
which are far removed from physiological reality. The 
mixed suspension, mixed product removal (MSMPR) 
crystallizer (or continuous crystallizer) first proposed by 
Finlayson [13) has been widely used in the study of cal-
cium oxalate crystallization processes [8, 35, 46) includ-
ing those involving UMM [9, 32, 42, 45). This system 
reaches a steady state with a constant supersaturation, 
and because it operates with continuous flow, individual 
crystals remain in the suspension for a relatively short 
time, similar to transit times through the kidney [30). 
Unlike other methods, it permits the simultaneous but 
independent measurement of nucleation and growth rates 
[30). A detailed description of the theoretical and prac-
tical aspects of the MSMPR crystallizer is given by 
Rodgers and Garside [46). 
Although UMM investigations using this type of 
crystallizer appear to have been limited to synthetic 
urines [9, 32, 42, 45], a new method using "nearly" 
whole urine has recently been developed [30). The ef-
fects of heparin and hyaluronic acid were tested success-
fully in the system. The MSMPR crystallizer is thus an 
appropriate system for a standard reference crystalliza-
tion model. 
Although we are encouraged by our application of 
flow cytometry to the study of UMM, we recognize that 
such a facility is not readily available to all researchers. 
Thus, of the different techniques used to detect and mon-
itor crystallization, Coulter Counter procedures appear 
to be the most versatile. Besides providing crystal size 
and crystal volume distribution profiles, crystal growth 
and aggregation can be measured, even when both are 
occurring simultaneously [52). A further advantage of 
using a Coulter Counter is its proven compatibility with 
the MSMPR crystallizer described earlier [8, 40, 45, 
46). Furthermore, by coupling these measurements to 
SEM investigations [23, 55], a powerful approach for 
differentiating between nucleation, growth and aggrega-
tion is achieved. 
Since it is generally agreed that the role of any uri-
nary component in promoting or inhibiting crystal for-
mation is highly dependent on its chemical milieu, stud-
ies on the role of UMM should be conducted in whole, 
real urines and not aqueous or synthetic solutions. Nor, 
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ideally, should filtered or sieved urine be used. Investi-
gators will be aware that crystals in the urine contain 
many macromolecules both on their surfaces as well as 
within their own structure. Many of these are crystalli-
zation modulators like prothrombin, osteopontin and uro-
modulin. In addition, when cellular debris is removed, 
much of the lipids and membranes are lost. Since it is 
widely accepted that these substances are intimately in-
volved in almost all physiological and pathological calci-
fication processes, their removal depletes the urine of 
crystallization promoters. Filtration may also remove 
many urinary macromolecules like Tamm-Horsfall pro-
tein, osteopontin and albumin. Thus, urine which has 
been sieved and filtered cannot be classified as "whole" 
urine. However, most investigators will agree that 
"whole" urine clogs up crystallizers and sensitive detec-
tors, many of which use small apertures, e.g., Coulter 
Counter. Use of "whole" urine is thus practically unfea-
sible; on the other hand, crystallization experiments 
using filtered and sieved urine are far more likely to be 
completed successfully. Thus, sieved and filtered urine 
would have to be the medium of choice for the standard 
system. Finally, since the excretion of many urinary 
components varies diurnally, 24-hour urine specimens 
should be used in these studies. The pH of the specimen 
should not be altered as it is a natural determinant 
property. Experiments should be performed at 37°C. 
Of great interest would be a comparative study in-
volving investigation of the same urine by the standard-
ized protocol described in this paper and by other sys-
tems. Perhaps an inter-laboratory "quality control" type 
of exercise could be implemented. Whatever the out-
come, unless investigators standardize their whole 
approach to the investigation of urinary macromolecular 
activity, discrepancies and lack of consensus on their 
role in urolithiasis are inevitable. 
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Discussion with Reviewers 
Reviewer I: What was the reproducibility of the 
results? For example, are the differences between UF 
and FILT significant? 
Authors: The reproducibility of the system was tested 
by measuring the calcium oxalate crystallization kinetics 
6 times in FILT fractions from each of three different 
urines. The coefficient of variation was 13 % . Kinetic 
data obtained in the experiments involving the urine 
reported in this paper were tested for significant differ-
ences by assuming that particle numbers and volumes 
have Poisson distributions [64]. All data were signifi-
cantly different after 90 minutes. 
Reviewer I: What was the osmolality of the urine? 
Authors: Osmolality was not measured. 
Reviewer I: The 24-hour collection may not resemble 
urine as actually passed. What are your comments? 
Authors: While you are correct in expressing this con-
cern, collection of 24-hour urine specimens for study is 
a widely practiced protocol. Whatever collection is ef-
fected (early morning, random, 12-hour, etc.), limita-
tions will always be present. 
J.P. Kavanagh: What was the ratio of the volumes of 
the RET and UF fractions at the end of the ultrafiltra-
tion? Any standard protocol for preparation of UMM 
should include this detail and also define sample collec-
tion and pre-treatment. 
Authors: The UF volume was 120 cm3 while that of 
the RET was 60 cm3• Since the original volume of 
FIL T in the ultrafiltration cell was 180 cm3, the RET 
fraction was concentrated by a factor of three. This 
concentration factor is recommended for the standard 
protocol as a larger one would be too far removed from 
physiological conditions while a smaller one might not 
induce detectable effects. Samples should be collected 
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in glass bottles which have been washed with hydrochlo-
ric acid and distilled water. No preservative should be 
present as it may affect crystallization. 
J.P. Kavanagh: It is not clear to me if a single experi-
ment was performed for each urinary fraction, with sam-
pling at intervals for analysis by Coulter Counter and 
flow cytometry, or if separate experiments were per-
formed. Factors other than the measuring technique 
might also influence the outcome of the crystallization 
experiments reported. Were there any differences in 
such details as sample age, vessel geometry or stirring? 
Authors: A single experiment with sampling at various 
times was performed. Since only one sample was used, 
age was not a variable. Vessel geometry and stirring 
were constant. 
J.P. Kavanagh: I share the authors' concern about the 
system dependence of results and the associated difficul-
ties in interpretation that this can lead to, but would a 
reference crystallization method resolve this difficulty? 
It is doubtful if any one method would always be appro-
priate for the questions being asked by different investi-
gators. On the other hand, there could be some merit in 
being able to compare baseline descriptions of crystalli-
zation modifying properties of urines or urinary fractions 
being tested. 
Authors: Investigators are using many different systems 
to answer a set of questions of common interest. Per-
haps an inter-laboratory "quality control" series of 
experiments (as discussed between the reviewer and 
author) might provide some (consistent) answers. 
S. Ebisuno: In Figures 7 to 9, two particle crystals 
show different patterns. However, it is impossible to 
understand the morphological difference because of lack 
of microscopy. 
Authors: The cytometer data only indicate a qualitative 
difference in particle morphology. In this study, two 
such shapes were detected; these have been interpreted 
as being associated with nucleation and aggregation. 
Although direct correlation with SEM studies was not 
achieved, examples of both mechanisms were observed 
using the latter technique. 
S. Ebisuno: How do you confirm the apatite deposits 
with embedded calcium oxalate dihydrate crystals in 
Figure 13? 
Authors: These deposits were confirmed by energy dis-
persive X-ray analysis which revealed the presence of 
Ca and P in the former and Ca in the latter. 
S. Ebisuno: The inhibitory activity of UMM on calci-
um oxalate crystal growth and/or aggregation is depend-
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ent on ionic strength (65]. Were there any differences 
in the ionic strengths of the three urinary fractions? 
Authors: This is a good point. Unfortunately, ionic 
strengths in the various urinary fractions were not 
determined. 
R.L. Ryall: Advances in protein chemistry and immu-
nological techniques have enabled us to study the effects 
of individual, identified urinary macromolecules on cal-
cium oxalate crystallization. Do the authors feel that 
useful information will be derived from studies based 
simply on global removal of all urinary macromolecules? 
Authors: Removal of all urinary macromolecules will 
identify the size ranges that are of importance. By care-
ful selection of membranes with different cut-offs, the 
effective size range can be accurately defined. Perhaps 
thereafter, immunological techniques should be used to 
identify the urinary macromolecules within such a range. 
R.L. Ryall: A call was made 15 years ago (reference 
41) for a standard system of nomenclature in urolithiasis 
research. Though more simple than a standard experi-
mental model, universal use of a reference nomenclature 
has never been achieved. How feasible would be the 
implementation of a standard reference model for study-
ing the inhibitory or promotory effects of macromole-
cules or other agents? 
Authors: The feasibility is directly dependent on the 
extent to which investigators are honest enough to recog-
nize that standardization of nomenclature, and a refer-
ence model would not only decrease the confusion that 
exists in this area of stone research but would also clar-
ify the inhibitory and promotory role of urinary macro-
molecules and other agents. 
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R.L. Ryall: I am most concerned about Figure 12. 
This micrograph clearly shows the presence of two red 
blood cells, and this suggests that the patient had 
haematuria. His urine therefore would have contained 
any number of additional macromolecules not found in 
urine under normal conditions. These would have af-
fected the inhibitory potency of the FILT and RET frac-
tions and their activity relative to the UF specimen. The 
presence of these red blood cells in urine that had been 
ultrafiltered indicates either that (a) the ultrafiltration 
was incomplete (the membrane may have been defective) 
or (b) the urine sample was later contaminated with 
blood, the patient's or someone else's. In either case, 
the validity of the data must be questioned. 
Authors: The two deposits referred to are not red blood 
cells. All our urine specimens used in crystallization 
and other studies are routinely tested for the presence of 
haematuria [ 49] using a Boehringer Mannheim Combur 
9 test strip (Boehringer, Mannheim, Germany). Urines 
which test positive are discarded [49]. The urine which 
was used in the present study was thus free of blood 
prior to ultrafiltration. We have seen these deposits, the 
morphology of which closely resembles that of red blood 
cells, in several of our crystallization experiments using 
urine from normal and stone-forming subjects. Energy 
dispersive (spot) X-ray analysis has revealed the 
presences of Na, K, S and Cl in these deposits. 
Therefore, it is likely that they are salts which have 
crystallized during our experiments. 
Additional References 
(64] Ratcliffe JF (1964) The significant difference 
between two Poisson variables. Appl Stat 13: 84-86. 
[65] Utsonomiya M, Koide T, Yoshioka S, 
Yamaguchi S, Okuyama A (1993) Influence of ionic 
strength on crystal adsorption and inhibitory activity of 
macromolecules. Br J Urol 71: 516-522. 
